← Back to Clinical Trials
Recruiting NCT07794332

NCT07794332 Symptom Assessment in Adolescents Placed on Child Welfare

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07794332
Status Recruiting
Phase —
Sponsor University Hospital, Strasbourg, France
Condition Complex Post-Traumatic Stress Disorder (CPTSD)
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2026-01-30
Primary Completion 2027-09-01

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 18 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2026-01-30 with a primary completion date of 2027-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to characterize emotional dysregulation in complex post-traumatic stress disorder (cPTSD) and to determine the extent to which it can promote the distinction with borderline personality disorder (BPD) and post-traumatic stress disorder (PTSD). As emotional dysregulation is a dynamic process whose phenomenological manifestations are labile, associated with physiological modifications and modulated by cognitive processing, a multiple methodology associating measurements in a real-life ecological context with measurements performed in the hospital will be preferred. Overall, this study proposes to capture, for the first time, the clinical manifestations associated with cPTSD from the perspective of emotional dysregulation and its underlying processes

Eligibility Criteria

Inclusion Criteria: * Adolescent aged 12 to 17 * Entrusted to ASE Bas-Rhin. * Fluent in French * Affiliated with a social health insurance scheme * Agreeing to take part in the study * Legal representative of the minor or his/her guardian, or his/her representative from the ASE agreeing to take part in the study. Exclusion Criteria: * Adolescent refusing to participate in the study * Legal representative of the minor or his/her guardian, or his/her ASE representative refusing to participate in the study * Adolescent with severe developmental delay * Adolescent participating in another research study * Adolescent deprived of liberty by judicial or administrative decision

Contact & Investigator

Central Contact

Carmen SCHRÖDER

✉ carmen.schroder@chru-strasbourg.fr

📞 0033388115248

Frequently Asked Questions

Who can join the NCT07794332 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Complex Post-Traumatic Stress Disorder (CPTSD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07794332 currently recruiting?

Yes, NCT07794332 is actively recruiting participants. Contact the research team at carmen.schroder@chru-strasbourg.fr for enrollment information.

Where is the NCT07794332 trial being conducted?

This trial is being conducted at Strasbourg, France.

Who is sponsoring the NCT07794332 clinical trial?

NCT07794332 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 200 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology